Amazon puts in $50 billion and gets $100 billion in cloud commitments back. Nvidia puts in $30 billion and earns it back in ...
AbbVie today announced positive topline results from the Phase 3, randomized, placebo-controlled, double-blind AFFIRM study evaluating the efficacy and safety of risankizumab (SKYRIZI®) subcutaneous ...
How a Former Enterprise Product Leader Is Building Technology to Preserve Identity, Strengthen Belonging, and Reconnect ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results